John M. Watkins

1.1k total citations
61 papers, 845 citations indexed

About

John M. Watkins is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, John M. Watkins has authored 61 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 12 papers in Oncology. Recurrent topics in John M. Watkins's work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (8 papers) and Breast Cancer Treatment Studies (7 papers). John M. Watkins is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (8 papers) and Breast Cancer Treatment Studies (7 papers). John M. Watkins collaborates with scholars based in United States, Canada and Sweden. John M. Watkins's co-authors include Robert F. Asarnow, Peter E. Tanguay, Anand K. Sharma, Elizabeth Garrett‐Mayer, Joseph M. Jenrette, Amy E. Wahlquist, Marian E. Williams, Eric Granholm, Keisuke Shirai and Joy K. Asamen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Child Psychology and Psychiatry and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

John M. Watkins

58 papers receiving 801 citations

Peers

John M. Watkins
Deborah McNally United Kingdom
Jesse D. Troy United States
Catherine T. Haring United States
Vanessa L. Merker United States
Deborah McNally United Kingdom
John M. Watkins
Citations per year, relative to John M. Watkins John M. Watkins (= 1×) peers Deborah McNally

Countries citing papers authored by John M. Watkins

Since Specialization
Citations

This map shows the geographic impact of John M. Watkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Watkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Watkins more than expected).

Fields of papers citing papers by John M. Watkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Watkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Watkins. The network helps show where John M. Watkins may publish in the future.

Co-authorship network of co-authors of John M. Watkins

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Watkins. A scholar is included among the top collaborators of John M. Watkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Watkins. John M. Watkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seyedin, Steven N., John M. Watkins, Anthony N. Snow, et al.. (2021). A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy. Advances in Radiation Oncology. 6(6). 100778–100778. 1 indexed citations
2.
Watkins, John M., Sarah L. Mott, Daniel J. Herr, et al.. (2020). Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer. Reports of Practical Oncology & Radiotherapy. 25(4). 489–493. 1 indexed citations
3.
Buatti, John M., et al.. (2017). Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity. European Thyroid Journal. 6(4). 187–196. 42 indexed citations
4.
Watkins, John M., Darrion Mitchell, Sarah L. Mott, et al.. (2016). Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning Analysis. Clinical Genitourinary Cancer. 15(2). 242–247. 2 indexed citations
5.
Mitchell, Darrion, Chad R. Tracy, John M. Buatti, et al.. (2015). Individualization of Adjuvant Therapy After Radical Prostatectomy for Clinically Localized Prostate Cancer: Current Status and Future Directions. Clinical Genitourinary Cancer. 14(1). 12–21. 7 indexed citations
6.
Wahlquist, Amy E., et al.. (2012). Clinical Investigations Impact of point A asymmetry on local control and survival for low dose-rate (LDR) brachytherapy in cervical cancer. Journal of Contemporary Brachytherapy. 1(1). 3–7. 3 indexed citations
7.
Harper, Jennifer L., et al.. (2010). Imaging applications in multicatheter brachytherapy for soft tissue sarcomas. Cancer Imaging. 10(1). 127–134.
8.
Watkins, John M., Keisuke Shirai, Jennifer L. Harper, et al.. (2010). Toxicity, Response Rates and Survival Outcomes of Induction Cisplatin and Irinotecan Followed by Concurrent Cisplatin, Irinotecan and Radiotherapy for Locally Advanced Esophageal Cancer. Japanese Journal of Clinical Oncology. 41(3). 334–342. 6 indexed citations
9.
Watkins, John M., et al.. (2010). High‐dose fractionated radiotherapy to 80 Gy for stage I–II medically inoperable non‐small‐cell lung cancer. Journal of Medical Imaging and Radiation Oncology. 54(6). 554–561. 2 indexed citations
10.
Watkins, John M., Keisuke Shirai, Amy E. Wahlquist, et al.. (2010). Cisplatin/Irinotecan Versus Carboplatin/Paclitaxel as Definitive Chemoradiotherapy for Locoregionally Advanced Esophageal Cancer. American Journal of Clinical Oncology. 33(4). 346–352. 38 indexed citations
11.
Watkins, John M., Amy E. Wahlquist, Keisuke Shirai, et al.. (2010). Once-daily radiotherapy to ≥59.4 Gy versus twice-daily radiotherapy to ≥45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes. Japanese Journal of Radiology. 28(5). 340–348. 18 indexed citations
12.
13.
Harper, Jennifer L., John M. Watkins, Amy E. Wahlquist, et al.. (2009). Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. The American Journal of Surgery. 199(2). 204–209. 11 indexed citations
14.
Watkins, John M., et al.. (2008). The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology. 141(2). 163–168. 7 indexed citations
15.
Watkins, John M., Jennifer L. Harper, Anthony E. Dragun, et al.. (2008). Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 7(4). 305–309. 23 indexed citations
16.
McRackan, Theodore R., John M. Watkins, Amy E. Herrin, et al.. (2008). Effect of Body Mass Index on Chemoradiation Outcomes in Head and Neck Cancer. The Laryngoscope. 118(7). 1180–1185. 69 indexed citations
17.
Watkins, John M., et al.. (2008). Helical tomotherapy for total lymphoid irradiation. Radiation Medicine. 26(10). 622–6. 7 indexed citations
18.
Watkins, John M., Amy E. Wahlquist, Keisuke Shirai, et al.. (2008). Factors Associated With Severe Acute Esophagitis From Hyperfractionated Radiotherapy With Concurrent Chemotherapy for Limited-Stage Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 74(4). 1108–1113. 14 indexed citations
19.
Watkins, John M., et al.. (2007). Definitive radiotherapy for medically inoperable early-stage serous and clear cell uterine carcinoma. Radiation Medicine. 25(10). 536–540. 4 indexed citations
20.
Watkins, John M., Robert F. Asarnow, & Peter E. Tanguay. (1988). SYMPTOM DEVELOPMENT IN CHILDHOOD ONSET SCHIZOPHRENIA. Journal of Child Psychology and Psychiatry. 29(6). 865–878. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026